Ozagrel Na intravenous infusion 80mg “IP”, manufactured by Neocriticare Pharmaceutical, contains sodium ozagrel. With YJ code 3999411A4083 and standard 80mg 4mL 1 tube, it functions as a thromboxane A2 synthetase inhibitor, often used to prevent cerebral vasospasm after subarachnoid hemorrhage.
Ozagrel Na intravenous infusion 80mg “IP”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →